SynthesisEndocrine2025

Clinical outcomes in type 2 diabetes patients with chronic heart failure treated with metformin: a meta-analysis.

What the trial testedas reported · 20,595 people · 2025

Not counted

−28%−40% to −13%

Bigger than 8 in 10 for all-cause mortality

As reported

RR 0.72, 95% CI 0.60–0.87 · the paper's word: All-cause mortality

Not counted

−48%−71% to −8%

Bigger than 9 in 10 for cardiovascular events

As reported

RR 0.52, 95% CI 0.29–0.92

the abstract, start to end

… risk of all-cause mortality (RR = 0.72, 95%CI: 0.60-0.87) and a notably lower risk of cardiovascular mortality (RR = 0.52, 95%CI:0.29-0.92).

← favours treatmentfavours comparator →

could be chance

All-cause mortality

RR 0.720.60–0.87

Cardiovascular events

RR 0.520.29–0.92

MetforminCardiovascular eventsAll-cause mortality

1 / 3

2024

2025

2026

this papercites it